Why Healthcare Brands Struggle to Connect with Clinicians When They Try to Sound Like Tech Companies
Introduction
There’s a growing trend in healthcare communications that deserves a hard stop: brands adopting the language, tone, and swagger of Silicon Valley.
The intent is obvious — sound innovative, fast‑moving, disruptive. The outcome is predictable — loss of trust, clinician skepticism, and a widening gap between what companies promise and what they can actually deliver.
Healthcare isn’t tech alone. When brands forget, clinicians and the market remind them.
The Problem with Borrowed Language
Tech companies can get away with sweeping verbs: revolutionize, disrupt, reinvent, transform.
Healthcare companies can’t — because the stakes are different.
In healthcare, every word is a claim. Every claim implies evidence. And every piece of evidence has to stand up against clinical, regulatory, and ethical scrutiny. When a healthcare brand uses tech‑style hype, it signals one thing to clinicians and operators: you don’t understand the space you’re in.
The Pattern
You don’t need to name‑and‑shame to see the pattern clearly.
Theranos built its entire narrative on tech‑bro vocabulary — “revolutionizing healthcare,” “transforming diagnostics,” “changing everything.” The language wasn’t the crime, but it was the tell: big promises, no clinical humility, no specificity.
Babylon Health leaned into “AI will replace the GP” and “healthcare reimagined.” Clinicians pushed back. Regulators stepped in. The gap between the promise and the clinical reality became impossible to ignore.
Pear Therapeutics marketed itself like a SaaS platform — “scalable,” “platform,” “digital disruption” — while operating in a regulated therapeutic environment. Investors bought the tech narrative; clinicians didn’t. The mismatch eroded trust long before the business collapsed.
Carbon Health initially framed itself as “bringing Silicon Valley speed to medicine.” The backlash from clinicians was immediate: medicine isn’t slow because it’s outdated, it’s slow because it’s careful.
Cue Health positioned diagnostics like a consumer gadget: “healthcare at the speed of life.” When performance issues surfaced, the tech‑style optimism clashed with the clinical scrutiny required in diagnostics.
Across the industry, AI‑in‑health startups continue to promise “revolutionary” capabilities with minimal evidence. The language is familiar. So is the outcome.
Why This Keeps Happening
Three forces drive this mistake:
1. Investor pressure
Tech investors expect velocity, scale, and category creation. Healthcare doesn’t move at that pace — and shouldn’t.
2. Brand insecurity
Early‑stage health companies often fear sounding “too clinical” or “too conservative,” so they overcorrect.
3. Misunderstanding the audience
Clinicians, operators, and regulators don’t want disruption. They want clarity, evidence, and operational alignment.
What Actually Builds Trust
If tech language erodes credibility, what strengthens it?
Clinical humility
Acknowledging complexity signals maturity, not weakness.
Specificity over slogans
“GMP‑certified, FDA‑registered, contact‑free processing” builds more trust than “revolutionary technology.”
Evidence‑aligned claims
Show the data. Show the process. Show the rigor. Just, keep the language easily digestible so that it actually connects with the humans reading it.
Operational transparency
In healthcare, how your work matters as much as what you build.
Mission that matches operations
Mission‑driven is meaningless unless the operations reflect it. You say you’re green, but are your operations?
The Opportunity for Healthcare Brands
The companies that win the next decade of healthcare innovation won’t be the ones who sound the most like tech startups. They’ll be the ones who communicate with the same rigor they operate with — clear, grounded, clinically aligned, and believable.
Healthcare doesn’t need disruption language. It needs:
· Precision
· Credibility
· Authenticity
· Narratives that respect the complexity of care
And the brands that embrace that will stand out.